Liraglutide
CGH-LiNASH
Novo Nordisk · Phase 3 · Status n/r · Enrollment 36
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Liraglutide | n/r | n/r | n/r | n/r | n/r |
| Bariatric Surgery | n/r | n/r | n/r | n/r | n/r |
| Diet modification and exercise | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.